Document is current

Any future updates will be listed below

Personalization of Neoadjuvant Immunotherapy in High-Risk Resectable Melanoma and Utility of ctDNA as a Biomarker of Immunotherapy Response

Crossref DOI link: https://doi.org/10.1245/s10434-026-19814-8

Published Online: 2026-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark